Suppr超能文献

嗜铬细胞瘤并不会增加腹腔镜肾上腺切除术的风险。

Pheochromocytoma does not increase risk in laparoscopic adrenalectomy.

机构信息

Center for Minimally Invasive Surgery, Ohio State University School of Medicine and Public Health, 410 West 10th Avenue, Columbus, OH 43210-1228, USA.

出版信息

Surg Endosc. 2010 Nov;24(11):2760-4. doi: 10.1007/s00464-010-1042-x. Epub 2010 Apr 8.

Abstract

BACKGROUND

Laparoscopic adrenalectomy (LA) has become the standard approach to an adrenal mass. This technique provides for decreased convalescence, less postoperative pain, and improved cosmesis. The use of LA for pheochromocytoma (PHE) has been questioned due to concerns of increased morbidity and negative hemodynamic sequelae. This study aimed to compare the outcomes of LA for PHE with the results of LA for other adrenal pathologies.

METHODS

A retrospective chart review was performed for an 11-year period from July 1997 to December 2008. Patient demographics, perioperative data, and outcomes were recorded. Statistical analysis was performed using SPSS 16.0. Statistical significance was defined as a p value less than 0.05.

RESULTS

A total of 102 LA procedures were completed for 95 patients. The data for 33 PHE cases were compared with the data for 69 non-PHE cases (26 adenomas, 14 aldosteronomas, 5 cortisol-secreting tumors, 5 multinodular hyperplasias, and 19 other disorders). Five LA procedures were converted to open surgery. Four of these conversions involved patients with PHE (p = 0.03). There was no difference in the mean estimated blood loss (p = 0.2) or operative time (p = 0.1) between the two groups. The frequency of intraoperative hypertension and hypotension did not differ between the PHE and non-PHE cohorts. The complication rate was 7.5% for the PHE group and 6.9% for the non-PHE group (p = 0.7). The patients with PHE had a longer postoperative hospital stay (3.6 vs 2.3 days; p < 0.001) and overall hospital stay (4.9 vs 2.6 days; p < 0.001). Time in the intensive care unit (1.1 vs 0.1 days; p < 0.001) and time until oral intake (1.5 vs 1.0 days; p = 0.02) also were increased in the PHE population. There was one death in the PHE group secondary to congestive heart failure.

CONCLUSIONS

Concerns of increased morbidity related to a laparoscopic approach for patients with a diagnosis of PHE are unfounded. In this series, the only disparity in outcomes between the two groups was an increased conversion rate with PHE.

摘要

背景

腹腔镜肾上腺切除术(LA)已成为治疗肾上腺肿块的标准方法。该技术可缩短恢复期、减少术后疼痛并改善美容效果。由于担心发病率增加和负面血流动力学后果,腹腔镜手术用于嗜铬细胞瘤(PHE)的应用受到质疑。本研究旨在比较 LA 治疗 PHE 与 LA 治疗其他肾上腺病变的结果。

方法

对 1997 年 7 月至 2008 年 12 月的 11 年期间进行了回顾性图表审查。记录患者人口统计学、围手术期数据和结果。使用 SPSS 16.0 进行统计分析。统计学意义定义为 p 值小于 0.05。

结果

共完成 102 例 LA 手术,共 95 例患者。将 33 例 PHE 病例的数据与 69 例非 PHE 病例(26 例腺瘤、14 例醛固酮瘤、5 例皮质醇分泌肿瘤、5 例多结节性增生和 19 例其他疾病)的数据进行比较。5 例 LA 手术转为开放手术。其中 4 例涉及 PHE 患者(p = 0.03)。两组之间平均估计出血量(p = 0.2)或手术时间(p = 0.1)无差异。术中高血压和低血压的发生率在 PHE 和非 PHE 两组之间没有差异。PHE 组的并发症发生率为 7.5%,非 PHE 组为 6.9%(p = 0.7)。PHE 组的术后住院时间(3.6 天与 2.3 天;p < 0.001)和总住院时间(4.9 天与 2.6 天;p < 0.001)较长。PHE 组在重症监护病房的时间(1.1 天与 0.1 天;p < 0.001)和开始口服摄入的时间(1.5 天与 1.0 天;p = 0.02)也增加。PHE 组有 1 例患者死于充血性心力衰竭。

结论

与腹腔镜治疗 PHE 患者相关的发病率增加的担忧是没有根据的。在本系列中,两组之间唯一的结果差异是 PHE 的转化率增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验